Remove featured-insights coronavirus-vaccines-progress
article thumbnail

Gibson Dunn Offers 2022 Year-End Securities Litigation Update

Reynolds Holding

We again survey securities-related litigation arising out of the coronavirus pandemic, including securities class actions alleging that defendants made false claims about the efficacy of their COVID-19 vaccines, treatments, and tests. Survey Of Coronavirus-Related Securities Litigation While governments around the U.S.